drug protocol number

IN457A3404

drug sponsor

Novartis

drug study

Cosyntex

drug trial site

King Khalid University Hospital (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah)

drug status

Ongoing

drug phase